TGFB1 and ovarian carcinoma: Obviously, further investigation toward delineating the mechanisms involved in the role of p53 mutation is essential, with emphasis on a “gain-of-function” mechanism related to DUBs rather than focusing on specific cross talk between TGF-β and the mutant p53 protein in ovarian cancer at the molecular level.